{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:29:20Z","timestamp":1790479760886,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1977,9,1]],"date-time":"1977-09-01T00:00:00Z","timestamp":241920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1977,9]]},"DOI":"10.1007\/bf01234510","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T05:45:12Z","timestamp":1109396712000},"page":"537-544","source":"Crossref","is-referenced-by-count":60,"title":["Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitus"],"prefix":"10.1007","volume":"13","author":[{"given":"J. E.","family":"Gerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. A.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. B.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-69-5-891","volume":"69","author":"D.M. Kipnis","year":"1969","unstructured":"Kipnis, D.M.: Insulin secretion in diabetes mellitus. Ann. Intern. Med.69, 891?901 (1969)","journal-title":"Ann. Intern. Med."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM197007232830405","volume":"283","author":"R. Levine","year":"1970","unstructured":"Levine, R., Haft, D.E.: Carbohydrate homeostasis. N. Engl. J. Med.283, 175?183, 237?246 (1970)","journal-title":"N. Engl. J. Med."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2337\/diab.22.11.834","volume":"22","author":"A. Kopf","year":"1973","unstructured":"Kopf, A., Tchobroutsky, G., Eschwege, E.: Serial postprandial blood glucose levels in 309 subjects with and without diabetes. Diabetes22, 834?840 (1973)","journal-title":"Diabetes"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2337\/diab.19.9.644","volume":"19","author":"F.J. Service","year":"1970","unstructured":"Service, F.J., Molnar, G.D., Rosevear, J.W., Ackerman, E., Gatewood, L.C., Taylor, W.F.: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes19, 644?655 (1970)","journal-title":"Diabetes"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0022-3476(76)81046-3","volume":"88","author":"J.I. Malone","year":"1976","unstructured":"Malone, J.I., Hellrung, J.M., Malphus, E.W., Rosenbloom, A.L., Grgic, A., Weber, F.T.: Good diabetic control ? a study in mass delusion. J. Pediatr.88, 943?947 (1976)","journal-title":"J. Pediatr."},{"key":"CR6","first-page":"666","volume-title":"Diabetes mellitus theory and practice","author":"H.C. Knowles Jr.","year":"1970","unstructured":"Knowles, H.C. Jr.: Control of diabetes and the progression of vascular disease. In: M. Ellenberg, H. Rifkin (Eds.): Diabetes mellitus theory and practice, pp. 666?673. New York: McGraw-Hill Book Company 1970"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.1971.03190220020005","volume":"218","author":"M.G. Goldner","year":"1971","unstructured":"Goldner, M.G., Knatterud, G.L., Prout, T.E.: Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. III. Clinical implications of the UGDP results. JAMA218, 1400?1410 (1971)","journal-title":"JAMA"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/diab.25.2.136","volume":"25","author":"R.H. Unger","year":"1976","unstructured":"Unger, R.H.: Diabetes and the alpha cell. Diabetes25, 136?151 (1976)","journal-title":"Diabetes"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1172\/JCI108364","volume":"57","author":"J.E. Gerich","year":"1976","unstructured":"Gerich, J.E., Lorenzi, M., Bier, D.M., Tsalikian, E., Schneider, V., Karam, J.H., Forsham, P.H.: Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism: studies involving administration of exogenous hormone during suppression of enogenous hormone secretion with somatostatin. J. Clin. Invest.57, 875?884 (1976)","journal-title":"J. Clin. Invest."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2337\/diab.23.9.783","volume":"23","author":"R. Luft","year":"1974","unstructured":"Luft, R., Guillemin, R.: Growth hormone and diabetes in man. Old concepts ? new implications. Diabetes23, 783?787 (1974)","journal-title":"Diabetes"},{"key":"CR11","first-page":"217","volume":"73","author":"O.H. Pearson","year":"1960","unstructured":"Pearson, O.H., Dominquez, J.M., Greenberg, E., Pazianos, A., Ray, B.S.: Diabetogenic and hypoglycemic effects of human growth hormone. Trans. Assoc. Am. Physicians73, 217?266 (1960)","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"CR12","first-page":"365","volume":"31","author":"W. Vale","year":"1975","unstructured":"Vale, W., Brazeau, P., Rivier, C., Brown, M., Boss, B., Rivier, J., Burgus, R., Ling, N., Guillemin, R.: Somatostatin. Recent Prog. Horm. Res.31, 365?397 (1975)","journal-title":"Recent Prog. Horm. Res."},{"key":"CR13","unstructured":"Burgus, R., Brazeau, P., Vale, W.: Isolation and determination of the primary structure of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin. DHEW Publications 74-612 (NIH) 144?158 (1973)"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.me.27.020176.002115","volume":"27","author":"R. Guillemin","year":"1976","unstructured":"Guillemin, R., Gerich, J.E.: Somatostatin: physiological and clinical significance. Annu. Rev. Med.27, 379?388 (1976)","journal-title":"Annu. Rev. Med."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02775444","volume":"11","author":"S.J. Konturek","year":"1976","unstructured":"Konturek, S.J.: Somatostatin and the gastrointestinal secretions. Scand. J. Gastroenterol.11, 1?4 (1976)","journal-title":"Scand. J. Gastroenterol."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01471574","volume":"54","author":"C. Lucke","year":"1976","unstructured":"Lucke, C., Mitzkat, H.J., von zur M\ufffdhlen, A.: Somatostatin ? a review. Klin. Wochenschr.54, 293?301 (1976)","journal-title":"Klin. Wochenschr."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1126\/science.184.4135.482","volume":"184","author":"D.J. Koerker","year":"1974","unstructured":"Koerker, D.J., Ruch, W., Chideckel, E., Palmer, J., Goodner, C.J., Ensinck, J., Gale, C.C.: Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science184, 482?484 (1974)","journal-title":"Science"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2337\/diabetes.25.7.550","volume":"25","author":"M.J. Guercio Del","year":"1976","unstructured":"Del Guercio, M.J., di Natale, B., Gargantini, L., Garlaschi, C., Chiumello, G.: Effect of somatostatin on blood sugar, plasma growth hormone, and glucagon levels in diabetic children. Diabetes25, 550?553 (1976)","journal-title":"Diabetes"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM197409122911102","volume":"291","author":"J.E. Gerich","year":"1974","unstructured":"Gerich, J.E., Lorenzi, M., Schneider, V., Karam, J.H., Rivier, J., Guillemin, R., Forsham, P.H.: Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. N. Engl. J. Med.291, 544?547 (1974)","journal-title":"N. Engl. J. Med."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(76)91338-6","volume":"I","author":"K. Lundbaek","year":"1976","unstructured":"Lundbaek, K., Hansen, Aa.P., \ufffdrskov, H., Christensen, S.E., Iversen, J., Seyer-Hansen, K., Alberti, K.G.M. M., Whitefoot, R.: Failure of somatostatin to correct manifest diabetic ketoacidosis. Lancet1976 I, 215?218","journal-title":"Lancet"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"299s","DOI":"10.1111\/j.1365-2265.1976.tb03838.x","volume":"5","author":"J.E. Gerich","year":"1976","unstructured":"Gerich, J.E., Schneider, V., Lorenzi, M., Tsalikian, E., Karam, J.H., Bier, D.M., Forsham, P.H.: Role of glucagon in human diabetic ketoacidosis: studies using somatostatin. Clin. Endocrinol.5 (Suppl), 299s-305s (1976)","journal-title":"Clin. Endocrinol."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.1975.03260150029015","volume":"234","author":"J.E. Gerich","year":"1975","unstructured":"Gerich, J.E., Lorenzi, M., Karam, J.H., Schneider, V., Forsham, P.H.: Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. JAMA234, 159?165 (1975)","journal-title":"JAMA"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2337\/diab.24.11.988","volume":"24","author":"C. Meissner","year":"1975","unstructured":"Meissner, C., Thum, Ch., Beischer, W., Winkler, G., Schr\ufffdder, K.E., Pfeiffer, E.F.: Antidiabetic action of somatostatin ? assessed by the artificial pancreas. Diabetes24, 988?996 (1975)","journal-title":"Diabetes"},{"key":"CR24","first-page":"461A","volume":"24","author":"J. Wahren","year":"1976","unstructured":"Wahren, J., Felig, P.: Somatostatin (SRIF) and glucagon in diabetes: failure of glucagon suppression to improve I. V. glucose tolerance and evidence of an effect of SRIF on glucose absorption. Clin. Res.24, 461A (1976)","journal-title":"Clin. Res."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJM197505082921901","volume":"292","author":"J.E. Gerich","year":"1975","unstructured":"Gerich, J.E., Lorenzi, M., Bier, D.M., Schneider, V., Tsalikian, E., Karam, J.H., Forsham, P.H.: Prevention of human diabetic ketoacidosis by somatostatin. N. Engl. J. Med.292, 985?989 (1975)","journal-title":"N. Engl. J. Med."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/jcem-38-1-77","volume":"38","author":"J.E. Gerich","year":"1974","unstructured":"Gerich, J.E., Schneider, V., Dippe, S.E., Langlois, M., Noacco, C., Karam, J.H., Forsham, P.H.: Characterization of the glucagon response to hypoglycemia in man. J. Clin. Endocrinol. Metab.38, 77?82 (1974)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2337\/diab.22.8.590","volume":"22","author":"S. Nakagawa","year":"1973","unstructured":"Nakagawa, S., Nakayama, H., Sasaki, T., Yoshino, K., Yu, Y.Y., Shinozaki, K., Aoki, S., Mashimo, K.: A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes22, 590?600 (1973)","journal-title":"Diabetes"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1056\/NEJM197509042931005","volume":"293","author":"C.H. Mielke","year":"1975","unstructured":"Mielke, C.H., Gerich, J.E., Lorenzi, M., Tsalikian, E., Rodvien, R., Forsham, P.H.: The effect of somatostatin on coagulation and platelet function in man. N. Engl. J. Med.293, 480?483 (1975)","journal-title":"N. Engl. J. Med."},{"key":"CR29","volume-title":"Management of juvenile diabetes mellitus","author":"H.S. Traisman","year":"1971","unstructured":"Traisman, H.S.: Management of juvenile diabetes mellitus, p. 54. St. Louis: C. V. Mosby Company 1971"},{"key":"CR30","first-page":"69","volume-title":"Therapy: criteria of control in diabetes mellitus diagnosis and treatment, vol. 1","author":"A. Marble","year":"1964","unstructured":"Marble, A.: Therapy: criteria of control in diabetes mellitus diagnosis and treatment, vol. 1, T. Danowski, (Ed.), pp. 69?71. New York: American Diabetes Association 1964"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0025-7125(16)33131-5","volume":"50","author":"F.D. Lukens","year":"1966","unstructured":"Lukens, F.D., Franklin, S.N.: Long-term diabetes without vascular disease. Med. Clin. North Am.50, 1385?1391 (1966)","journal-title":"Med. Clin. North Am."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1172\/JCI107986","volume":"55","author":"E.W. Chideckel","year":"1975","unstructured":"Chideckel, E.W., Palmer, J., Koerker, D.J., Ensinck, J., Davidson, M.B., Goodner, C.J.: Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis. J. Clin. Invest.55, 754?762 (1975)","journal-title":"J. Clin. Invest."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(74)92071-6","volume":"II","author":"F.P. Alford","year":"1974","unstructured":"Alford, F.P., Bloom, S.R., Nabarro, J.D.N., Hall, R., Besser, G.M., Coy, D.H., Kastin, A.J., Schally, A.V.: Glucagon control of fasting glucose in man. Lancet1974 II, 974?976","journal-title":"Lancet"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI107886","volume":"54","author":"H. Sakurai","year":"1974","unstructured":"Sakurai, H., Dobbs, R., Unger, R.H.: Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs. J. Clin. Invest.54, 1395?1402 (1974)","journal-title":"J. Clin. Invest."},{"key":"CR35","unstructured":"Gerich, J.E., Bier, D., Haas, R., Wood, C., Byrne, R., Penhos, J.: In vitro and in vivo effects of somatostatin on glucose, alanine, and ketone body metabolism in the rat, p. 128. Prog. 57th Annual Meeting of the Endocrine Society, New York, June 18?20, 1975"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.1166308","volume":"190","author":"G. Boden","year":"1975","unstructured":"Boden, G., Sivitz, M.C., Owen, O.E., Essa-Koumar, N., Landar, J.H.: Somatostatin suppresses secretin and pancreatic exocrine secretion. Science190, 163?165 (1975)","journal-title":"Science"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI108438","volume":"58","author":"S.J. Konturek","year":"1976","unstructured":"Konturek, S.J., Tasler, J., Obtulowicz, W., Coy, D.H., Schally, A.V.: Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J. Clin. Invest.58, 1?6 (1976)","journal-title":"J. Clin. Invest."},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(74)90869-1","volume":"II","author":"S.R. Bloom","year":"1974","unstructured":"Bloom, S.R., Mortimer, C.H., Thorner, M.O., Besser, G.M., Hall, R., Gomez-Pan, A., Roy, V.M., Russell, R.C.G., Coy, D.H., Kastin, A.J., Schally, A.V.: Inhibition of gastrin and gastric acid secretion by growth-hormone release-inhibiting hormone. Lancet1974 II, 1106?1109","journal-title":"Lancet"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000197691","volume":"13","author":"S. Raptis","year":"1975","unstructured":"Raptis, S., Dollinger, H.C., von Berger, L., Schlegel, W., Schr\ufffdder, K., Pfeiffer, E.: Effects of somatostatin on gastric secretion and gastrin release in man. Digestion13, 15?26 (1975)","journal-title":"Digestion"},{"key":"CR40","first-page":"155A","volume":"24","author":"J.W. Ensinck","year":"1976","unstructured":"Ensinck, J.W., Laschansky, E., Knoeber, M., Johnson, D., Benson, J., Goodner, C.J.: Distribution of somatostatin (S) measured by radioimmunoassay. Clin. Res.24, 155A (1976)","journal-title":"Clin. Res."},{"key":"CR41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM197509042931004","volume":"293","author":"D.J. Koerker","year":"1975","unstructured":"Koerker, D.J., Harker, L.A., Goodner, C.J.: Effects of somatostatin on hemostasis in baboons. N. Engl. J. Med.293, 476?479 (1975)","journal-title":"N. Engl. J. Med."}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01234510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01234510\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01234510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T06:01:43Z","timestamp":1556776903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01234510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1977,9]]}},"alternative-id":["BF01234510"],"URL":"https:\/\/doi.org\/10.1007\/bf01234510","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977,9]]}}}